3D tissue-engineered model of Ewing's sarcoma

This publication has 231 references indexed in Scilit:

• ERBB4 confers metastatic capacity in Ewing sarcoma
  EMBO Molecular Medicine, 2013
• Combination testing (Stage 2) of the Anti‐IGF‐1 receptor antibody IMC‐A12 with rapamycin by the pediatric preclinical testing program
  Pediatric Blood & Cancer, 2011
• Bone marrow cells participate in tumor vessel formation that supports the growth of Ewing’s sarcoma in the lung
  Angiogenesis, 2010
• Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three‐dimensional lung cancer xenograft model
  Cancer, 2010
• Angiogenesis and vascular targeting in Ewing sarcoma
  Cancer, 2009
• Pellet culture elicits superior chondrogenic redifferentiation than alginate‐based systems
  Biotechnology Progress, 2009
• Dendritic Cell-Ewing’s Sarcoma Cell Hybrids Enhance Antitumor Immunity
  Clinical Orthopaedics and Related Research, 2008
• Stromal cell‐derived factor‐1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor
  International Journal of Cancer, 2008
• VEGF165 expression in the tumor microenvironment influences the differentiation of bone marrow-derived pericytes that contribute to the Ewing’s sarcoma vasculature
  Angiogenesis, 2008
• Ewing's sarcoma lines synthesize laminin and fibronectin
  Virchows Archiv, 1987